Insider Transactions in Q3 2025 at Sab Biotherapeutics, Inc. (SABS)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2025
|
Andrew Moin |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,740,000
+44.18%
|
$1,740,000
$1.75 P/Share
|
|
Sep 29
2025
|
Sessa Capital (Master), L.P. Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,740,000
+44.18%
|
$1,740,000
$1.75 P/Share
|
|
Sep 19
2025
|
Alexandra Kropotova CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,977
-4.18%
|
-
|